揭示隐藏障碍:荷兰儿科药物警戒面临的挑战
该研究通过横断面调查评估荷兰儿科医生(含受训者)对药品不良反应(ADR)报告的认识与障碍。127名受访者中93%知晓如何报告,95%认为报告可提升知识并改善用药安全,但19%从未报告过ADR;最常见未报告原因(61%)为已知该ADR。研究提示需针对儿科ADR报告障碍采取措施。
要点
- 多数儿科医生认可ADR报告价值,但19%从未报告。
- 未报告首要原因是已知该ADR,占61%。
- 其他障碍包括不确定症状是否为ADR、认为不严重及时间限制。
核心结论
- 荷兰儿科医生普遍认可ADR报告的重要性,但多种障碍影响实际报告行为。
研究设计与样本
- 在荷兰儿科医生(含受训者)中开展的横断面问卷调查,共纳入127名受访者。
主要发现
- 93%的受访者知晓如何报告ADR。
- 95%认为报告ADR可提升知识并改善用药安全。
- 93%认可ADR报告的整体重要性。
- 19%的受访者表示从未报告过ADR。
- 61%的受访者将已知该ADR列为未报告的最常见原因。
临床怎么用
- 临床药学智能体应关注儿科ADR报告障碍,协助医生识别不确定症状是否为ADR并简化报告流程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The use of drugs carries risks, as adverse drug reactions (ADRs) can occur. In the Netherlands, a voluntary pharmacovigilance system is in place, allowing healthcare professionals and patients to report (suspected) ADRs. Previous research has highlighted underreporting as a significant problem; however, barriers for ADR reporting are not clear. OBJECTIVES: The aim was to assess perceptions of ADR reporting among pediatricians (in training), to identify barriers hindering reporting, and to study differences between our hospital and other Dutch hospitals. METHODS: A cross-sectional survey was conducted among pediatricians (in training) in the Netherlands. The study questionnaire was based on a validated questionnaire and adjusted for the Dutch context, addressing aspects related to ADR reporting, attitudes toward ADRs in work environment, personal vision, reasons for nonreporting, and future perspectives. RESULTS: A dataset of 127 respondents was included. Of these, 93% reported knowing how to report an ADR. Overall, 95% believed that reporting ADRs has the potential to enhance knowledge and improve drug safety, and 93% acknowledged the overall importance of ADR reporting. However, 19% of respondents indicated that they had never reported an ADR. The most commonly cited reason (61%) for not reporting was prior knowledge of the ADR. Other barriers included uncertainty about whether a symptom constituted an ADR, the perception that the ADR was not severe, and time constraints. CONCLUSIONS: This study highlights the importance of addressing barriers to ADR reporting in pediatric healthcare. While healthcare professionals recognize the significance of ADR reporting, several impediments hinder their reporting efforts.
引用
- Dittrich ATM, Kroeze Y, Willemsen MAAP, et al. Uncovering the Hidden Hurdles: Exploring Challenges in Pediatric Pharmacovigilance in the Netherlands. Drug Saf. 2025. PMID: 40753519. doi:10.1007/s40264-025-01593-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。